Adma Biologics (ADMA) Net Margin (QoQ) (2012 - 2025)

Adma Biologics (ADMA) Net Margin (QoQ) (2012 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Adma Biologics 2.13 Bn 2.00 Bn 86.28 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -12,291.00
Sep 30, 2025 -91.00
Jun 30, 2025 462.00
Mar 31, 2025 -1,899.00
Dec 31, 2024 1,246.00
Sep 30, 2024 5.00
Jun 30, 2024 816.00
Mar 31, 2024 741.00
Dec 31, 2023 1,200.00
Sep 30, 2023 1,293.00
Jun 30, 2023 133.00
Mar 31, 2023 1,167.00
Dec 31, 2022 1,264.00
Sep 30, 2022 -1,791.00
Jun 30, 2022 4,411.00
Mar 31, 2022 -3,791.00
Dec 31, 2021 6,122.00
Sep 30, 2021 1,982.00
Jun 30, 2021 870.00
Mar 31, 2021 4,253.00